| Literature DB >> 33022905 |
Gabriela Torres Silva1, Carolina Di Pietro Fernandes2, Priscila Aiko Hiane1, Karine de Cássia Freitas1, Priscila Silva Figueiredo1, Aline Carla Inada1, Wander Fernando Filiú2, Iriani Rodrigues Maldonade3, Ângela Alves Nunes4, Lincoln Carlos Silva de Oliveira5, Anderson Rodrigues Lima Caires6, Flavio Michels6, Camila Jordão Candido1, Leandro Fontoura Cavalheiro5, Marcel Arakaki Asato7, Juliana Rodrigues Donadon1, Bernardo Bacelar de Faria8, Mariana Bento Tatara9, Julio Henrique Rosa Croda9,10, Arnildo Pott2, Carlos Eduardo Domingues Nazário5, Rita de Cássia Avellaneda Guimarães1.
Abstract
The fruit of Caryocar brasiliense Cambess. is a source of oil with active compounds that are protective to the organism. In our work, we analyzed the physicochemical characteristics and evaluated the effects of supplementation with C. brasiliense oil in an animal model. We characterized the oil by indices of quality and identity, optical techniques of absorption spectroscopy in the UV-Vis region and fluorescence, and thermogravimetry/derived thermogravimetry (TG/DTG). For the animal experiment, we utilized mice (Mus musculus) supplemented with lipidic source in different dosages. The results demonstrated that C. brasiliense oil is an alternative source for human consumption and presents excellent oxidative stability. Primarily, it exhibited oleic MFA (53.56%) and palmitic SFA (37.78%). The oil level of tocopherols and tocotrienols was superior to the carotenoids. The supplementation with C. brasiliense oil reduced the levels of total cholesterol, LDL-c, and non-HDL-c. Regarding visceral fats and adiposity index, the treatment synergically supplemented with olive oil and C. brasiliense oil (OO + CO) obtained the best result. Therefore, C. brasiliense oil is a high quality product for consumption. Its supplementation promotes beneficial effects mainly on the lipidic profile.Entities:
Keywords: fatty acids; natural products; pequi
Mesh:
Substances:
Year: 2020 PMID: 33022905 PMCID: PMC7582708 DOI: 10.3390/molecules25194530
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Indices of quality and identity of Caryocar brasiliense pulp oil.
| Index | Values |
|---|---|
| Peroxide index (mEq O2 kg−1) | 13.63 ± 0.97 |
| Acidity index in oleic acid (mg KOH/g−1) | 1.27 ± 0.02 |
| Saponification index (mg KOH g−1) | 136.5 ± 0.60 |
| Refraction index at 40 °C | 1.46 ± 0.00 |
| Iodine index (g I2 100−1 g) | 76.7 ± 0.72 |
| Relative density | 0.57 ± 0.00 |
| L* | 36.6 ± 0.03 |
| C* | 22.2 ± 0.02 |
| h (deg) | 74.3 ± 0.04 |
| a* | 6.0 ± 0.02 |
| b* | 21.4 ± 0.05 |
| Carotenoids (µg/g) | 2.39 ± 0.04 |
The results are expressed as the means ± mean standard error.
Figure 1Molecular absorption spectra of Caryocar brasiliense oil, obtained at 200–600 nm.
Figure 2Excitation–emission map of Caryocar brasiliense oil obtained by exciting between 200 and 400 nm and in the emission 250 and 600 nm range. (a) Caryocar brasiliense oil at 5 × 10−3 g mL−1 concentration; (b) Undiluted Caryocar brasiliense oil.
Figure 3Thermogravimetry/derivate thermogravimetry (TGA/DTG). Curves of Caryocar brasiliense oil.
Figure 4Electrical conductivity versus time determined by the Rancimat method in Caryocar brasiliense oil.
Fatty acids profile of Caryocar brasiliense pulp oil (% in area).
| Fatty Acids | Values |
|---|---|
|
| |
| Butyric. C4:0 | 0.04 ± 0.01 |
| Mystiric. C14:0 | 0.08 ± 0.00 |
| Palmitic. C16:0 | 37.78 ± 1.07 |
| Heptadecanoic. C17:0 | 0.05 ± 0.00 |
| Stearic. C18:0 | 1.84 ± 0.00 |
| Arachidic. C20:0 | 0.19 ± 0.02 |
| Behenic. C22:0 | 0.06 ± 0.01 |
| Lignoceric. C24:0 | 0.07 ± 0.01 |
| TOTAL | 40.04 |
|
| |
| Palmitoleic. C16:1 | 0.57 ± 0.01 |
| Oleic. C18:1 (𝜔-9) | 52.61 ± 1.06 |
| Cis-11- eicosenic. C20:1 | 0.19 ± 0.00 |
| TOTAL | 53.56 |
|
| |
| Linoleic. C18:2 (𝜔-6) | 3.9 ± 0.15 |
| 0.40 ± 0.00 | |
| 0.04 ± 0.00 | |
| TOTAL | 4.34 |
The results are expressed as the means ± mean standard error.
Biochemical parameters of animals after 90 days of Caryocar brasiliense oil supplementation.
| Parameters (mg dL−1) | CG | OO1 | OO2 | CO1 | CO2 | OOCO |
|---|---|---|---|---|---|---|
| Total cholesterol | 188.79 ± 9.18 | 177.68 ± 9.59 | 163.22 ± 10.80 | 134.61 ± 5.29 *,§ | 138.90 ± 6.01 *,§ | 149.85 ± 5.15 * |
| HDL-c | 120.93 ± 5.18 | 119.62 ± 7.48 | 118.54 ± 6.37 | 97.26 ± 4.08 | 109.33 ± 6.13 | 111.75 ± 5.74 |
| LDL-c | 43.88 ± 5.02 | 33.36 ± 6.25 | 19.65 ± 6.05 * | 14.10 ± 1.42 * | 6.58 ± 1.88 *,§ | 15.47 ± 2.60 * |
| Non-HDL-c | 69.10 ± 5.90 | 58.05 ± 6.46 | 44.68 ± 6.77 | 37.35 ± 1.88 * | 29.57 ± 1.83 *,§ | 38.08 ± 2.91 * |
| VLDL-c | 23.97 ± 4.18 | 24.70 ± 3.06 | 25.03 ± 3.31 | 23.25 ± 3.95 | 22.99 ± 2.35 | 22.62 ± 2.67 |
| Triglycerides | 188.77 ± 5.80 | 123.49 ± 4.43 | 125.16 ± 4.26 | 116.25 ± 5.27 | 114.97 ± 2.72 | 113.14 ± 3.86 |
| Glucose | 180.64 ± 21.50 | 179.12 ± 16.78 | 234.46 ± 13.19 | 216.68 ± 14.47 | 191.90 ± 10.33 | 229.29 ± 13.89 |
CG indicates control group, supplemented with soybean oil (1000 mg/kg); OO1 and OO2 groups receiving olive oil (1000 mg/kg and 2000 mg/kg, respectively); CO1 and CO2 groups supplemented with C. brasiliense oil (1000 mg/kg and 2000 mg/kg, respectively); and OO + CO group receiving olive oil (1000 mg/kg) with C. brasiliense oil (10 C. brasiliense oil 00 mg/kg). Values represent the mean ± mean standard error. * p ≤ 0.05 vs. CG; § p ≤ 0.05 vs. OO1. ANOVA: one-way analysis of variance with Tukey post hoc test.
Bodyweight, liver, and visceral fats weight (g) of animals supplemented with different lipid sources.
| Parameters | CG | OO1 | OO2 | CO1 | CO2 | OOCO |
|---|---|---|---|---|---|---|
| Initial weight (g) | 39.231 ± 1.277 | 37.692 ± 1.157 | 40.286 ± 1.197 | 39.429 ± 1.561 | 38.500 ± 1.185 | 39.333 ± 0.873 |
| Final weight (g) | 48.923 ± 1.916 | 48.615 ± 1.591 | 52.714 ± 1.535 | 51.286 ± 1.871 | 47.429 ± 1.349 | 46.333 ± 2.028 |
| Omental weight (g) | 0.073 ± 0.011 | 0.050 ± 0.009 | 0.053 ± 0.006 | 0.038 ± 0.007 * | 0.031 ± 0.006 * | 0.026 ± 0.004 * |
| Epididymal weight (g) | 1.970 ± 0.224 | 1.817 ± 0.123 | 1.715 ± 0.175 | 1.583 ± 0.177 | 1.281 ± 0.134 * | 1.055 ± 0.132 *,§ |
| Mesenteric weight (g) | 1.008 ± 0.110 | 0.970 ± 0.095 | 1.083 ± 0.164 | 0.847 ± 0.107 | 0.850 ± 0.115 | 0.528 ± 0.074 *,§,¥ |
| Retroperitoneal weight (g) | 0.693 ± 0.088 | 0.670 ± 0.065 | 0.488 ± 0.064 | 0.462 ± 0.066 | 0.363 ± 0.047 *,§ | 0.330 ± 0.036 *,§ |
| Perirenal weight (g) | 0.391 ± 0.046 | 0.368 ± 0.047 | 0.304 ± 0.050 | 0.212 ± 0.030 * | 0.209 ± 0.031 * | 0.151 ± 0.017 *,§ |
| Adiposity index (%) | 8.290 ± 0.620 | 7.888 ± 0.378 * | 6.799 ± 0.632 * | 5.986 ± 0.567 | 5.640 ± 0.515 § | 4.422 ± 0.436 *,§,¥ |
| Liver (g) | 1.70 ± 0.086 | 1.66 ± 0.070 | 1.55 ± 0.118 | 1.43 ± 0.093 | 1.33 ± 0.035 *,§ | 1.40 ± 0.046 |
CG indicates control group, supplemented with soybean oil (1000 mg/kg); OO1 and OO2 groups receiving olive oil (1000 mg/kg and 2000 mg/kg, respectively); CO1 and CO2 groups supplemented with Caryocar brasiliense oil (1000 mg/kg and 2000 mg/kg, respectively); and OO + CO group receiving olive oil (1000 mg/kg) with C. brasiliense oil (1000 mg/kg). Values represent the mean ± mean standard error. * p ≤ 0.05 vs. CG; § p ≤ 0.05 vs. OO1; ¥ p ≤ 0.05 vs. OO2. ANOVA: one-way analysis of variance with Tukey post hoc test.
Distribution of changes observed in the liver of the animals in the experimental groups.
| Variable | CG | OO1 | OO2 | CO1 | CO2 | OOCO |
|---|---|---|---|---|---|---|
| Steatosis ( | ||||||
| <5% | 36.36 (4) | 60.0 (6) | 80.0 (8) | 80.0 (8) | 40.0 (4) | 66.7 (6) |
| 5–33% | 18.18 (2) | 20.0 (2) | 10.0 (1) | 10.0 (1) | 40.0 (4) | 33.3 (3) |
| 33–66% | 45.45 (5) | 20.0 (2) | 10.0 (1) | 10.0 (1) | 20.0 (2) | 0.0 (0) |
| Microvesicular Steatosis ( | ||||||
| Absent | 81.8 (9) | 90.0 (9) | 100.0 (10) | 90.0 (9) | 100.0 (10) | 88.9 (8) |
| Present | 18.2 (2) | 10.0 (1) | 0.0 (0) | 10.0 (1) | 0.0 (0) | 11.1 (1) |
| Lobular Inflammation ( | ||||||
| Absent | 54.6 (6) | 70.0 (7) | 50.0 (5) | 50.0 (5) | 20.0 (2) | 77.8 (7) |
| <2 focus | 45.4 (5) | 30.0 (3) | 50.0 (5) | 50.0 (5) | 70.0 (7) | 22.2 (2) |
| 2–4 focuses | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 10.0 (1) | 0.0 (0) |
| Ballooning ( | ||||||
| Absent | 72.7 (8) | 80.0 (8) | 20.0 (2) | 0.0 (0) | 10.0 (1) | 0.0 (0) |
| Few cells | 27.3 (3) | 20.0 (2) | 20.0 (2) | 30.0 (3) | 30.0 (3) | 11.1 (1) |
| Many cells | 0.0 (0) | 0.0 (0) | 40.0 (6) | 70.0 (7) | 60.0 (6) | 88.9 (8) |
| Mallory’s Hyaline ( | ||||||
| Absent | 100.0 (11) | 80.0 (8) | 40.0 (4) | 20.0 (2) | 40.0 (4) | 11.1 (1) |
| Rare | 0.0 (0) | 20.0 (2) | 40.0 (4) | 40.0 (4) | 40.0 (4) | 66.7 (6) |
| Some | 0.0 (0) | 0.0 (0) | 20.0 (2) | 40.0 (4) | 20.0 (2) | 22.2 (2) |
| Apoptosis ( | ||||||
| Absent | 81.8 (9) | 100.0 (10) | 70.0 (7) | 20.0 (2) | 30.0 (3) | 44.4 (4) |
| Present | 18.2 (2) | 0.0 (0) | 30.0 (3) | 80.0 (8) | 70.0 (7) | 55.6 (5) |
| Glycogenated Nuclei ( | ||||||
| None/rare | 100.0 (11) | 90.0 (9) | 100.0 (10) | 90.0 (9) | 100.0 (10) | 88.9 (8) |
| Some | 0.0 (0) | 10.0 (1) | 0.0 (0) | 10.0 (1) | 0.0 (0) | 11.1 (1) |
CG indicates control group, supplemented with soybean oil (1000 mg/kg); OO1 and OO2 groups receiving olive oil (1000 mg/kg and 2000 mg/kg, respectively); CO1 and CO2 groups supplemented with Caryocar brasiliense oil (1000 mg/kg and 2000 mg/kg, respectively); and OO + CO group receiving olive oil (1000 mg/kg) with C. brasiliense oil (1000 mg/kg). Data are presented in relative frequency (absolute frequency). p-value in the chi-square test. Due to the sample size, two categories were grouped as follows: A ≤ 5% and ≥5%; B = Absent and Present, * p ≤ 0.05.
Distribution of changes observed in animal pancreas in each experimental group.
| Variable | Experimental Group % (n) | |||||
|---|---|---|---|---|---|---|
| CG | OO1 | OO2 | CO1 | CO2 | OOCO | |
| Islet of Langerhans ( | ||||||
| No change | 45.4 (5) | 33.33 (3) | 36.4 (4) | 33.33 (3) | 45.4 (5) | 36.4 (4) |
| Discrete atrophy | 36.4 (4) | 66.7 (6) | 33.33 (3) | 33.33 (3) | 33.33 (3) | 33.33 (3) |
| Atrophy | 0.0 (0) | 0.0 (0) | 22.2 (2) | 33.3 (3) | 11.1 (1) | 0.0 (0) |
| Hypertrophy | 9.1 (1) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 22.2 (2) |
| Not available | 9.1 (1) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 0.0 (0) |
| Pancreatic Acini (B) | ||||||
| No change | 100.0 (11) | 100.0 (9) | 100.0 (9) | 100.0 (9) | 100.0 (9) | 100.0 (9) |
| Inflammatory Cells ( | ||||||
| No change | 100.0 (11) | 100.0 (9) | 88.9 (8) | 100.0 (9) | 100.0 (9) | 100.0 (9) |
| Insulits | 0.0 (0) | 0.0 (0) | 11.1 (1) | 0.0 (0) | 0.0 (0) | 0.0 (0) |
CG indicates control group, supplemented with soybean oil (1000 mg/kg); OO1 and OO2 groups receiving olive oil (1000 mg/kg and 2000 mg/kg, respectively); PO1 and PO2 groups supplemented with Caryocar brasiliense oil (1000 mg/kg and 2000 mg/kg, respectively); and OO + CO group receiving olive oil (1000 mg/kg) with C. brasiliense oil (1000 mg/kg). Data are presented in relative frequency (absolute frequency). p-value in the chi-square test. (A) Due to the sample size, the categories were grouped into No change and with change; (B) Inferential statistical analysis due to the absence of variability between groups.
Figure 5Effects of supplementation from different lipid source on anti- and proinflammatory cytokines. (a) Interleukin-6; (b) Interleukin-10; (c) Monocyte-1 chemotactic protein; (d) Tumor necrosis factor alpha. CG indicates control group, supplemented with soybean oil (1000 mg/kg); OO1 and OO2 groups receiving olive oil (1000 mg/kg and 2000 mg/kg, respectively); CO1 and CO2 groups supplemented with Caryocar brasiliense oil (1000 mg/kg and 2000 mg/kg, respectively); and OO + CO group receiving olive oil (1000 mg/kg) with C. brasiliense oil (1000 mg/kg). ANOVA: one-way analysis of variance.
Figure 6Intervention protocol of the supplementation with Caryocar brasiliense oil. CG indicates control group, supplemented with soybean oil (1000 mg/kg); OO1 and OO2 groups receiving olive oil (1000 mg/kg and 2000 mg/kg, respectively); CO1 and CO2 groups supplemented with C. brasiliense oil (1000 mg/kg and 2000 mg/kg, respectively); and OO + CO group receiving olive oil (1000 mg/kg) with C. brasiliense oil (1000 mg/kg).